Estrogen and Other Cognition-Enhancing Drugs
Estrogen and Other Cognition-Enhancing Drugs
This chapter discusses the pros and cons of using estrogen and cognition-enhancing drugs in treating neuropsychiatric conditions, and presents health risks related to a decrease in estrogen levels in middle-age women, including Alzheimer’s disease, depression, and cognitive impairment. The use of hormone-replacement therapy for women during and after menopause, whose estrogen levels were low, was questioned following the Women’s Health Initiative report of risks and benefits of estrogen replacement. The chapter presents studies on the use of cognition-enhancing drugs by healthy, older individuals. The use of amphetamines to enhance cognition in older people is discussed along with its drawback of being addictive. The chapter discusses the positive effect of caffeine on improving cognition and its impact on the pathology of Alzheimer’s disease.
Keywords: estrogen, cognition-enhancing drugs, neuropsychiatric conditions, hormone-replacement therapy, Alzheimer’s disease
MIT Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.
